Procter & Gamble Health Stock Screener | Share Price & Fundamental Analysis
PGHL
Pharmaceuticals
Screen Procter & Gamble Health share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹5740.50
▼
-103.50 (-1.77%)
Share Price BSE
₹5751.70
▼
-86.25 (-1.48%)
Market Cap
₹9,429.28 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
15.27
EPS (TTM)
₹141.00
Dividend Yield
2.19%
Debt to Equity
0.01
52W High
₹6581.50
52W Low
₹5002.60
Operating Margin
32.00%
Profit Margin
23.60%
Revenue (TTM)
₹1,301.00
EBITDA
₹431.00
Net Income
₹307.00
Total Assets
₹794.00
Total Equity
₹537.00
Procter & Gamble Health Share Price History - Stock Screener Chart
Screen PGHL historical share price movements with interactive charts. Analyze price trends and patterns.
Procter & Gamble Health Company Profile - Fundamental Screener
Screen Procter & Gamble Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PGHL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE199A01012
Procter & Gamble Health Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen PGHL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 | 784 |
| Current Assets | 526 | 524 | 796 | 608 | 727 | 954 | 1,534 | 752 | 636 | 572 |
| Fixed Assets | 116 | 129 | 144 | 112 | 104 | 101 | 104 | 115 | 111 | 132 |
| Liabilities | ||||||||||
| Total Liabilities | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 | 784 |
| Current Liabilities | 42 | 37 | 46 | 40 | 44 | 42 | 27 | 33 | 29 | 27 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 537 | 538 | 751 | 617 | 704 | 906 | 1,540 | 733 | 664 | 592 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | 520 | 522 | 734 | 600 | 687 | 890 | 1,524 | 717 | 647 | 575 |
Screen PGHL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,301 | 945 | 1,167 | 1,248 | 1,128 | 1,027 | 1,425 | 873 | 722 | 1,017 | 963 |
| Expenses | 869 | 616 | 845 | 905 | 847 | 763 | 1,041 | 701 | 621 | 877 | 856 |
| EBITDA | 431 | 329 | 322 | 343 | 281 | 264 | 384 | 173 | 101 | 140 | 107 |
| Operating Profit % | 32.00% | 34.00% | 27.00% | 26.00% | 24.00% | 24.00% | 23.00% | 17.00% | 11.00% | 12.00% | 9.00% |
| Depreciation | 23 | 17 | 27 | 28 | 27 | 30 | 30 | 21 | 19 | 25 | 23 |
| Interest | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 408 | 312 | 273 | 314 | 253 | 233 | 355 | 158 | 99 | 115 | 83 |
| Tax | 103 | 77 | 72 | 85 | 61 | 57 | 101 | 56 | 38 | 36 | 30 |
| Net Profit | 307 | 234 | 201 | 230 | 193 | 177 | 254 | 102 | 61 | 79 | 54 |
| EPS | 184.80 | 141.00 | 121.00 | 138.00 | 116.00 | 107.00 | 153.00 | 505.27 | 56.60 | 47.70 | 32.30 |
Procter & Gamble Health Cash Flow Screener - Liquidity Fundamentals
Screen PGHL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 169 | 228 | 236 | 170 | 247 | 235 | -130 | 54 | 107 | 84 |
| Investing Activities | 10 | -7 | -22 | -26 | -32 | 165 | 1,270 | -48 | -75 | -68 |
| Financing Activities | -235 | -418 | -99 | -289 | -387 | -883 | -30 | -22 | -15 | -12 |
| Net Cash Flow | -57 | -197 | 116 | -145 | -172 | -483 | 1,109 | -16 | 17 | 4 |
Screen PGHL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FII Holding | 6.87% | 6.99% | 7.24% | 6.24% | 6.40% | 6.61% | 7.02% | 0.00% |
| DII Holding | 14.21% | 14.16% | 13.91% | 13.73% | 14.55% | 14.84% | 14.71% | 12.31% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 21.90% | 21.89% | 22.15% | 22.61% | 21.82% | 21.46% | 21.34% | 24.09% |
| Other Holding | 5.21% | 5.14% | 4.89% | 5.60% | 5.41% | 5.28% | 5.12% | 11.78% |
| Shareholder Count | 53,993 | 52,478 | 50,006 | 56,778 | 55,923 | 54,792 | 53,736 | 61,030 |
Procter & Gamble Health Dividend Screener - Share Yield Analysis
Screen PGHL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹125.00 | 2.19% |
| 2024-March | ₹260.00 | 5.05% |
| 2023-March | ₹95.00 | 2.02% |
| 2022-March | ₹52.50 | 1.12% |
| 2021-March | ₹130.00 | 3.25% |
| 2020-March | ₹230.00 | 3.71% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹440.00 | 11.91% |
| 2017-March | ₹15.00 | 1.00% |
Procter & Gamble Health Index Membership - Market Screener Classification
Screen PGHL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Procter & Gamble Health Market Events Screener - Corporate Actions
Screen PGHL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 1.13% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -3.34% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | 1.83% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 45.00 /share | 10.63% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 0.33% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 5.91% |
| 2025-02-21 | 2025-02-21 | Dividend | ₹ 80.00 /share | 1.63% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.43% |
| 2024-12-05 | 2024-12-05 | Annual General Meeting | NA | -0.50% |
| 2024-11-28 | 2024-11-29 | Dividend | ₹ 60.00 /share | -4.69% |
| 2024-11-04 | 2024-11-04 | Quarterly Result Announcement | NA | -1.04% |
| 2024-02-14 | 2024-02-14 | Dividend | ₹ 150.00 /share | 7.15% |
| 2024-02-14 | 2024-02-14 | Dividend | ₹ 50.00 /share | 7.15% |
| 2023-11-30 | 2023-11-30 | Annual General Meeting | NA | -3.53% |
| 2023-11-23 | 2023-11-24 | Dividend | ₹ 50.00 /share | -5.37% |
Procter & Gamble Health Competitors Screener - Peer Comparison
Screen PGHL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 410,142 | 39.35 | 54,729 | 9.71% | 10,980 | 38.94 |
| Divis Laboratories | 168,705 | 68.31 | 9,712 | 18.67% | 2,191 | 47.61 |
| Torrent Pharmaceuticals | 129,831 | 60.76 | 11,539 | 6.99% | 1,911 | 63.27 |
| Cipla | 121,376 | 22.46 | 28,410 | 7.12% | 5,291 | 50.85 |
| Dr Reddys Laboratories | 104,554 | 18.49 | 33,741 | 16.73% | 5,725 | 53.02 |
| Lupin | 95,243 | 22.19 | 22,910 | 13.74% | 3,306 | 57.47 |
| Zydus Life Science | 91,577 | 18.30 | 23,511 | 18.55% | 4,615 | 43.59 |
| Mankind Pharma | 89,591 | 51.11 | 12,744 | 20.90% | 2,007 | 49.10 |
| Aurobindo Pharma | 68,157 | 20.05 | 32,346 | 9.43% | 3,484 | 45.26 |
| Alkem Laboratories | 64,517 | 27.31 | 13,458 | 3.70% | 2,216 | 41.76 |
Procter & Gamble Health Company Announcements - News Screener
Screen PGHL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-01 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On February 6 2026. | View |
| 2026-01-01 | Closure of Trading Window | View |
| 2025-11-18 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-05 | Outcome Of Board Meeting For The Quarter Ended September 30 2025 | View |
| 2025-11-05 | Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended September 30 2025 | View |
| 2025-10-20 | Revision of Board Meeting | View |
| 2025-10-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Allotment Of DIN To Mr. Shashank Srowthy Executive Director | View |
| 2025-09-29 | Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 5 2025 | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-16 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-16 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | View |
| 2025-09-16 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-09-08 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-01 | Change In Senior Management Personnel Of The Company | View |
| 2025-08-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |